Trademark: 97461363
Status Date
Thursday, February 8, 2024
Filing Date
Thursday, June 16, 2022
Published for Opposition
Tuesday, June 13, 2023
44 providing medical information to patients and healthcare professionals in the form of reports in the field of pharmaceutical-gene interactions including the delivery and interpretation of pharmacogenetic test results and recommendations; providing medical information to patients and healthcare professionals in the form of reports in the field of pharmacogenetic analysis
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2024
Sou Extension 1 Granted
Feb 8, 2024
Sou Extension 1 Filed
Feb 8, 2024
Sou Teas Extension Received
Aug 8, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 13, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 13, 2023
Published For Opposition
May 24, 2023
Notification Of Notice Of Publication E-Mailed
May 8, 2023
Approved For Pub - Principal Register
Apr 20, 2023
Teas/Email Correspondence Entered
Apr 19, 2023
Correspondence Received In Law Office
Apr 19, 2023
Teas Response To Office Action Received
Feb 24, 2023
Notification Of Non-Final Action E-Mailed
Feb 24, 2023
Non-Final Action E-Mailed
Feb 24, 2023
Non-Final Action Written
Feb 10, 2023
Teas/Email Correspondence Entered
Feb 10, 2023
Correspondence Received In Law Office
Feb 10, 2023
Teas Response To Office Action Received
Nov 15, 2022
Notification Of Non-Final Action E-Mailed
Nov 15, 2022
Non-Final Action E-Mailed
Nov 15, 2022
Non-Final Action Written
Nov 15, 2022
Assigned To Examiner
Jun 30, 2022
New Application Office Supplied Data Entered
Jun 20, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
